Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of On-Demand Xyntha in Chinese Hemophilia A Subjects
NCT00868530Phase 3Completed
- Sponsor
- Pfizer
- Start
- Sep 2008
- Primary completion
- Dec 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of moroctocog alfa in hemophilia A, sponsored by Pfizer. Started Sep 2008; status: completed.
02
Drugs
moroctocog alfa
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT00868530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00868530.